Precision Microbiome Medicines
Microbiotica (microbiotica.com) scores 74 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 37th percentile of 10836 Healthcare brands.
Microbiotica is a healthcare company focused on translating clinic-led microbiome science into medicines. It uses a clinic-led discovery platform to identify bacteria associated with patient outcomes, aiming to develop defined live biotherapeutic products with known mechanisms of action. The company targets diseases such as cancer and inflammatory bowel disease, positioning itself as a precision medicine company serving pharmaceutical partners, investors, and patients seeking microbiome-based therapeutics.
| Brand Name | Microbiotica |
|---|---|
| Domain | microbiotica.com |
| Industry | Healthcare |
| Main Competitors | Seres Therapeutics (75/100), Vedanta Biosciences (74/100), Enterome (77/100), MaaT Pharma (73/100), Evelo Biosciences, Finch Therapeutics (71/100) |
Moz Domain Authority 33/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "To translate clinic-led microbiome science into transformative life-changing medicines." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: Microdata (Schema.org), canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Apache, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, Facebook, Instagram, YouTube, GitHub; no detected presence on X (Twitter) - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Microbiotica?", Claude could identify the brand as of September 2026. Microbiotica is a UK biotech company, spun out of the Wellcome Sanger Institute, that develops microbiome-based diagnostics and therapeutics, using its reference genome database of gut bacteria to identify biomarkers and new treatments for diseases linked to the gut microbiome. Best known for Developing microbiome-based diagnostics and therapeutics using a proprietary gut bacteria reference database derived from Sanger Institute research.
When asked "Best brands similar to Microbiotica?", Claude would recommend Microbiotica as of September 2026. It's a notable player in the microbiome therapeutics and diagnostics space with strong scientific pedigree, so it would come up in discussions of leading microbiome biotech companies.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Microbiotica's main competitors in Healthcare: Seres Therapeutics (75/100), Vedanta Biosciences (74/100), Enterome (77/100), MaaT Pharma (73/100), Finch Therapeutics (71/100).
Sources: Brand Analyzer scan
Microbiotica has limited AI-search visibility, scoring 27/100 on Brand Analyzer's AI visibility composite (visibility 17, trust 26, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Microbiotica official site
Microbiotica scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Microbiotica official site
Microbiotica is a precision medicine company that develops microbiome-based therapeutics, translating clinic-led microbiome science into medicines for diseases such as cancer and inflammatory bowel disease.
Sources: Microbiotica official site
Microbiotica uses a clinic-led discovery platform to identify specific bacteria linked to patient outcomes, and develops these findings into defined live biotherapeutic products with known mechanisms of action, targeting conditions like immuno-oncology and inflammatory bowel disease.
Sources: Microbiotica official site
Microbiotica can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Microbiotica official site
Microbiotica offers defined live biotherapeutic products (LBPs) developed through its clinic-led discovery platform, targeting immuno-oncology and inflammatory bowel disease, with therapeutics designed around known mechanisms of action derived from bacteria linked to patient clinical outcomes.
Sources: Microbiotica official site
Microbiotica is known for its clinic-led approach to microbiome drug discovery, which identifies bacteria associated with clinical patient outcomes to create precisely defined live biotherapeutic products.
Sources: Microbiotica official site
Microbiotica's offerings are aimed at pharmaceutical partners seeking microbiome-based drug candidates, investors interested in precision medicine therapeutics, and ultimately patients with immuno-oncology and inflammatory bowel disease who may benefit from targeted microbiome therapies.
Sources: Microbiotica official site
Microbiotica scores 27/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Microbiotica has a weak AI-visibility profile at 27/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (17/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 33/100 and thin schema.org structured data. In a live check, Claude could already identify Microbiotica from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Microbiotica: Mevion Medical Systems (74/100), Mevex (STERIS AST) (74/100), Milann (74/100), Millie Moon (74/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.